Mobic and Spironolactone drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Mobic (meloxicam) and Spironolactone (spironolactone). Common drug interactions include rotator cuff syndrome among females and fall among males.
The phase IV clinical study analyzes what interactions people have when they take Mobic and Spironolactone. It is created by eHealthMe based on reports of 383 people who take the same drugs from the FDA, and is updated regularly.
What is Mobic?
Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 26,684 Mobic users. Check the latest studies of Mobic.
What is Spironolactone?
Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 122,947 Spironolactone users. Check the latest studies of Spironolactone.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
383 people who take Mobic and Spironolactone together, and have interactions are studied.
What are the common drug interactions of Mobic and Spironolactone, by gender? *
What are the common drug interactions of Mobic and Spironolactone, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Mobic and Spironolactone?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Mobic (26,684 reports)
- Spironolactone (122,947 reports)
Browse all drug interactions of Mobic and Spironolactone:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Mobic:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Spironolactone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mobic and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Spironolactone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on meloxicam and spironolactone (the active ingredients of Mobic and Spironolactone, respectively), and Mobic and Spironolactone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pneumonia and drugs of ingredients of ciclesonide - now
- Could Eligard cause Feeling Hot? - now
- Cardiac Failure Chronic and drugs of ingredients of hydroxyzine hydrochloride - a second ago
- Rashes and drugs of ingredients of ferric citrate - 2 seconds ago
- Bladder Disorder and drugs of ingredients of hydromorphone hydrochloride - 4 seconds ago
- Fluid Retention and drugs of ingredients of amiodarone hydrochloride - 7 seconds ago
- Thyroid Cancer and Hypotension - 11 seconds ago
- Serotonin Syndrome and drugs of ingredients of zonisamide - 12 seconds ago
- Losartan and Bradycardia for Women aged 60+ - 12 seconds ago
- Losartan and Slow Rhr for Women aged 60+ - 13 seconds ago